SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea
· Delayed Price · Currency is KRW 4,450.00
-30.00 (-0.67%)
At close: Mar 6, 2026
SELVAS Healthcare Revenue
SELVAS Healthcare had revenue of 6.71B KRW in the quarter ending September 30, 2025, a decrease of -21.97%. This brings the company's revenue in the last twelve months to 29.79B, up 1.77% year-over-year. In the year 2024, SELVAS Healthcare had annual revenue of 31.70B with 6.34% growth.
Revenue (ttm)
29.79B
Revenue Growth
+1.77%
P/S Ratio
3.66
Revenue / Employee
232.73M
Employees
128
Market Cap
109.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.70B | 1.89B | 6.34% |
| Dec 31, 2023 | 29.81B | 2.13B | 7.68% |
| Dec 31, 2022 | 27.69B | -1.40B | -4.82% |
| Dec 31, 2021 | 29.09B | 7.94B | 37.52% |
| Dec 31, 2020 | 21.15B | -1.20B | -5.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remed | 24.26B |
| Noul Co.,Ltd. | 3.91B |
| QuantaMatrix | 3.35B |
| Hironic | 33.18B |
| Neofect | 20.50B |
| JPI Healthcare | 52.79B |
| L&K Biomed | 40.33B |
| DRGEM | 98.34B |